Biohaven Ltd. (BHVN) has disclosed a new risk, in the Regulation category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Biohaven Ltd. faces broad exposure to operational, financial, and market events that could weaken its financial condition, impair operating performance, and pressure the trading price of its securities. It also acknowledges that its overall risk profile remains largely consistent with the material risks previously detailed in Part I, Item 1A of its Form 10-K for the year ended December 31, 2025, filed with the SEC on March 2, 2026.
Overall, Wall Street has a Moderate Buy consensus rating on BHVN stock based on 8 Buys and 3 Holds.
To learn more about Biohaven Ltd.’s risk factors, click here.